A recent study revealed that CD163+ TAMs promoted expression of IL-6 and CXCL2 by cancer cells while inhibition of either IL-6 or CD163 macrophage-induced tumorigenesis in a co-culture in vitro system and a sarcoma mouse model (Shiraishi et al., 2018). The gene discussed is CD163; the disease is sarcoma.